Jun 26, 2018
The hepatitis B crisis is a worldwide unmet medical need. Hepatitis B (HBV) is the cause of a silent epidemic that has resulted in a worldwide healthcare crisis. Despite the significant burden it places on communities across the globe, hepatitis had been mainly ignored as a health and clinical development priority until recently.
Hepatitis B infections are a leading cause of disability and death worldwide. In fact, hepatitis causes as many deaths annually as tuberculosis, AIDs or malaria. Unlike many other infectious diseases, the absolute burden and relative risk of developing viral hepatitis has actually increased in recent years. Despite the availability of vaccines to help prevent hepatitis B, the coverage rate remains poor in highly endemic areas.
This article was written by Dr John Sullivan-Bolyai
If you'd like to view the original article then follow the link below:
http://www.ddw-online.com/therapeutics/p315862-an-update-on-hepatitis-b-therapies.html
You can also download the original article pdf here:
http://www.ddw-online.com/media/32/114686/an-update-on-hepatitis-b-therapies.pdf
For more information on Drug Discovery World, head to: